documents: FDA-2023-D-5016-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-D-5016-0002 FDA FDA-2023-D-5016 Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Guidance for Industry - Draft Guidance Other Guidance 2024-12-30T05:00:00Z 2024 12 2024-12-30T05:00:00Z 2025-03-01T04:59:59Z 2025-10-16T09:00:23Z   1 0 0900006486894c0f

Links from other tables